IE 11 is not supported. For an optimal experience visit our site on another browser.
  • Kansas City Mayor: Public transportation, broadband are key infrastructure

    02:16
  • Sen. Stabenow on Build Back Better: 'We are in the final days of negotiation'

    05:26
  • What happens when a woman is denied an abortion

    04:02
  • Josephine Baker to become first Black woman inducted into France's Panthéon

    01:08
  • Miami, Sacramento mayors explain how infrastructure law could help cities across U.S.

    03:10
  • Hundreds stranded in airports across the globe as borders close

    01:38
  • Food insecurity and the challenges of getting food on the table as prices rise

    04:03
  • Congress works to pass government funding, Build Back Better Act by end of the year

    03:15
  • 51% of shoppers plan to shop online Thanksgiving Day

    07:37
  • Court order over Jan. 6 documents could be bad sign for Trump

    01:23
  • Rep. Jimmy Gomez on impact of nearly $2T social spending bill

    05:43
  • Mexican military arrests wife of notorious drug lord 'El Mencho'

    03:34
  • Danny Cevallos analyzes trial in the killing of Ahmaud Arbery

    07:40
  • Dr. Patel on vaccine boosters, Pfizer Covid pill

    02:43
  • Rep. Clyburn on reconciliation, child tax credit, Rep. Gosar censure vote

    06:41
  • 'QAnon Shaman' to be sentenced for role in Jan. 6 riot

    02:28
  • As Cuban government stifles planned demonstrations, solidarity protests held around world

    03:41
  • Russia missile test blamed for space debris that forced astronauts to take shelter

    03:39
  • Pfizer agrees to let other companies make its Covid pill to expand global access

    01:47
  • 'Total military shutdown': Cuban government cracks down ahead of planned protests

    10:57

Pfizer agrees to let other companies make its Covid pill to expand global access

01:47

Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental Covid-19 pill, a move that could make the treatment available to more than half of the world’s population. Earlier this month, Pfizer said the pill cut the risk of hospitalization and death by nearly 90 percent in people with mild to moderate infections. Dr. Nahid Bhadelia joins José Díaz-Balart to discuss.